Form 4: Lipocine Director Buys Shares
Insider Transaction (Form 4)
John W. Higuchi, a Director of Lipocine Inc., purchased 25,007 shares of common stock on September 29, 2026.
Summary
- Open-market purchase: acquired 9,037 Common stock at $2.15 ($19,430) on September 29, 2026; holds 225,395 after (Direct).
- Open-market purchase: acquired 15,970 Common stock at $2.23 ($35,613) on September 30, 2026; holds 241,365 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $55,043, committing personal capital to the stock.
Insider Transactions
John W. Higuchi — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-29 | Open-market purchase | Common stock | 9,037 | $2 | $19.4K | 225,395 |
| 2026-09-30 | Open-market purchase | Common stock | 15,970 | $2 | $35.6K | 241,365 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-29 | Open-market purchase (9,037 shares) |
| 2026-09-30 | Open-market purchase (15,970 shares) |
Keywords
insider transaction, Form 4, LPCN, Lipocine Inc., bullish, John W. Higuchi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.